About: In vitro glycosidation potential towards Olomoucine - type cyclin-dependent kinase inhibitors in rodent and primate microsomes     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
Description
  • Mezidruhové rozdíly v glykosidaci v savčích tkáních ukazují na nejednoznačnosti při extrapolaci endobiotických a xenobiotických cest ze zvířat na člověka. (cs)
  • Interspecies differences in glycosidation potential in mammalian tissues represent a factor contributing to ambiguity when endobiotic and/or xenobiotic metabolic pathways are extrapolated from animals to man. Using the TLC/autoradiographic technique, we conducted an in vitro investigation involving mouse, rat, monkey, as well as human liver and kidney microsomes to evaluate their glycoconjugation potential towards (3)H-labeled, purine-derived selective inhibitors of cyclin-dependent kinases such as olomoucine, bohemine, roscovitine, 6-(2-hydroxybenzyl)amino-2-(1-hydroxymethyl-2-methylpropyl)amino-9-isopropylpurine (compound A-4), and 6-(3-hydroxybenzyl)amino-2-[(1(R/S)-hydroxymethyl)propyl]amino-9-isopropylpurine (compound A-5) as aglycones. Principally, this study confirmed the aliphatic hydroxyl group of olomoucine-type inhibitors as a relatively suitable target for glucuronide, glucoside, xyloside, galactoside, and/or N-acetylaminoglucoside conjugation. Of the tissues examined, only the mouse micro
  • Interspecies differences in glycosidation potential in mammalian tissues represent a factor contributing to ambiguity when endobiotic and/or xenobiotic metabolic pathways are extrapolated from animals to man. Using the TLC/autoradiographic technique, we conducted an in vitro investigation involving mouse, rat, monkey, as well as human liver and kidney microsomes to evaluate their glycoconjugation potential towards (3)H-labeled, purine-derived selective inhibitors of cyclin-dependent kinases such as olomoucine, bohemine, roscovitine, 6-(2-hydroxybenzyl)amino-2-(1-hydroxymethyl-2-methylpropyl)amino-9-isopropylpurine (compound A-4), and 6-(3-hydroxybenzyl)amino-2-[(1(R/S)-hydroxymethyl)propyl]amino-9-isopropylpurine (compound A-5) as aglycones. Principally, this study confirmed the aliphatic hydroxyl group of olomoucine-type inhibitors as a relatively suitable target for glucuronide, glucoside, xyloside, galactoside, and/or N-acetylaminoglucoside conjugation. Of the tissues examined, only the mouse micro (en)
Title
  • In vitro glycosidation potential towards Olomoucine - type cyclin-dependent kinase inhibitors in rodent and primate microsomes
  • In vitro glycosidation potential towards Olomoucine - type cyclin-dependent kinase inhibitors in rodent and primate microsomes (en)
  • Glykosidace in vitro za účelem inhibitoru cyklin dependentní kinázy olomoucinového typu a v mikrosomech hlodavců a primátů (cs)
skos:prefLabel
  • In vitro glycosidation potential towards Olomoucine - type cyclin-dependent kinase inhibitors in rodent and primate microsomes
  • In vitro glycosidation potential towards Olomoucine - type cyclin-dependent kinase inhibitors in rodent and primate microsomes (en)
  • Glykosidace in vitro za účelem inhibitoru cyklin dependentní kinázy olomoucinového typu a v mikrosomech hlodavců a primátů (cs)
skos:notation
  • RIV/61989592:15110/03:00007270!RIV09-MSM-15110___
http://linked.open...avai/riv/aktivita
http://linked.open...avai/riv/aktivity
  • P(GA301/02/0475), P(OC B17.20), V, Z(MSM 151100001)
http://linked.open...iv/cisloPeriodika
  • 4
http://linked.open...vai/riv/dodaniDat
http://linked.open...aciTvurceVysledku
http://linked.open.../riv/druhVysledku
http://linked.open...iv/duvernostUdaju
http://linked.open...titaPredkladatele
http://linked.open...dnocenehoVysledku
  • 610059
http://linked.open...ai/riv/idVysledku
  • RIV/61989592:15110/03:00007270
http://linked.open...riv/jazykVysledku
http://linked.open.../riv/klicovaSlova
  • glycosidation; mouse; rat; monkey; human; CDK inhibitors (en)
http://linked.open.../riv/klicoveSlovo
http://linked.open...odStatuVydavatele
  • CZ - Česká republika
http://linked.open...ontrolniKodProRIV
  • [C22FE7582D7E]
http://linked.open...i/riv/nazevZdroje
  • Physiological Research (print)
http://linked.open...in/vavai/riv/obor
http://linked.open...ichTvurcuVysledku
http://linked.open...cetTvurcuVysledku
http://linked.open...vavai/riv/projekt
http://linked.open...UplatneniVysledku
http://linked.open...v/svazekPeriodika
  • 52
http://linked.open...iv/tvurceVysledku
  • Havlíček, Libor
  • Hanuš, Jan
  • Veselý, Jaroslav
  • Rypka, Miroslav
  • Fuksová, Květoslava
  • Černý, B.
  • Chmela, Zdeněk
  • Riegrová, Dagmar
  • Belejová, Marie
  • Červenková, Kateřina
  • Michalíková, K.
  • Brejcha, A.
  • Michnová, K.
  • Šúrová, I.
http://linked.open...n/vavai/riv/zamer
issn
  • 0862-8408
number of pages
http://localhost/t...ganizacniJednotka
  • 15110
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 48 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software